= Discovery stage. (16.60%, 2024)
= Translation stage. (37.02%, 2024)
= Clinically available. (46.38%, 2024)
No entry found.
Financial Disclosure
Description
Y/N
Source
Grants
no
Salary
no
Board Member
no
Stock
no
Expenses
no
IP Royalty
no
Planning to mention or discuss specific products or technology of the company(ies) listed above:
no